Acasti Pharma Inc (ACST)

Etorro trading 970x250
Acasti Pharma Inc (ACST) Logo

About Acasti Pharma Inc

Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of prescription drugs for the treatment of cardiovascular diseases. Its lead product candidate is CaPre, an omega-3 phospholipid therapeutic that is in Phase III clinical trial to treat patients with hypertriglyceridemia; and TRILOGY that is in Phase III to evaluate the safety and efficacy of CaPre in patients with sHTG. The company was incorporated in 2002 and is headquartered in Laval, Canada. Address: 545, Promenade du Centropolis, Laval, QC, Canada, H7T 0A3

Acasti Pharma Inc News and around…

Latest news about Acasti Pharma Inc (ACST) common stock and company :

Monteverde & Associates PC Filed A Class Action Lawsuit On Behalf Of Shareholders Of Acasti Pharma, Inc. In The Southern District Of New York
07 Oct, 2021 Yahoo! Finance

NEW YORK, NY / ACCESSWIRE / October 7, 2021 / Notice is hereby given that Monteverde & Associates PC has filed a class action lawsuit in the United States District Court the Southern District of New York, Case No. 1:21-cv-06051-KPF, on behalf of public common shareholders of Acasti Pharma, Inc.

Acasti Pharma Awarded Composition-of-Matter Patents for GTX-101 in Europe, China and Mexico and for GTX-102 in Japan
06 Oct, 2021 Yahoo! Finance

Patents strengthen Acasti’s IP portfolio and provide protection through 2036 and 2037, respectivelyLAVAL, Québec, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today announces that the European Patent Office, Chinese Patent Office and the Mexican Patent Office have issued composition of matter patents for GTX-101, a novel bio-adhesive film forming topical spray formulation of bupivacaine for the treatment of Postherpetic Neuralgi

Acasti Pharma Announces Initiation of Pharmacokinetic Bridging Study for GTX-104, the Company’s Lead Drug Candidate for the Treatment of Subarachnoid Hemorrhage
27 Sep, 2021 FinancialContent

Study expected to be completed in the first half of 2022, with the goal to commence the Phase 3 safety study in the second half of 2022

Acasti Pharma Provides Update Following Acquisition of Grace Therapeutics and Regains Compliance with Nasdaq Listing Standards
22 Sep, 2021 FinancialContent
Acasti Pharma to Present at the Oppenheimer Fall Healthcare Summit on September 21ˢᵗ
14 Sep, 2021 FinancialContent
Here are several penny stocks and others to watch next week
12 Sep, 2021 FinancialContent
Acasti Pharma to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
08 Sep, 2021 FinancialContent
55 Biggest Movers From Yesterday
01 Sep, 2021 FinancialContent

Gainers Unico American Corporation (NASDAQ: UNAM) shares gained 59% to close at $4.15 on Tuesday. Elys Game Technology, Corp. ...

Why Shares of Acasti Pharma Slumped Tuesday
31 Aug, 2021 FinancialContent

The clinical-stage pharmaceutical company completed its merger with Grace Therapeutics last week.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
30 Aug, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips The weekend is officially over and that means it's time to jump back into investing with a look at Monday's biggest pre-market stock movers! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

28 Stocks Moving in Monday's Pre-Market Session
30 Aug, 2021 FinancialContent

Gainers Vinco Ventures, Inc. (NASDAQ: BBIG) rose 86.1% to $9.87 in pre-market trading after jumping over 80% on Friday. The ...

Acasti Pharma Announces Successful Completion of its Merger with Grace Therapeutics, Inc., Voting Results of its Annual and Special Meeting of Shareholders and Reverse Stock Split
27 Aug, 2021 FinancialContent
21 Stocks Moving in Wednesday's Pre-Market Session
25 Aug, 2021 FinancialContent

Gainers Regencell Bioscience Holdings Limited (NASDAQ: RGC) rose 40.1% to $21.43 in pre-market trading after gaining over 11% on ...

Are These Penny Stocks on Your Watchlist Right Now?
12 Aug, 2021 FinancialContent
Acasti Pharma Provides Business Update for the First Quarter of Fiscal 2022
12 Aug, 2021 FinancialContent
Reminder: Acasti Pharma to Host Conference Call on August 4th at 1:00 PM ET to Discuss Planned Acquisition of Grace Therapeutics
29 Jul, 2021 FinancialContent
Best Penny Stocks to Buy in August? 4 for Your Watchlist
24 Jul, 2021 FinancialContent
Acasti Pharma Schedules Conference Call for August 4th at 1:00 PM ET to Discuss Planned Acquisition of Grace Therapeutics
23 Jul, 2021 FinancialContent

All shareholders are strongly encouraged to vote in advance of the August 26, 2021, annual and special meeting of shareholders

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
14 Jul, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, investors! We're kicking off the day with a look at winners and losers of the biggest pre-market stock movers for Wednesday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now It doesn’t matter if you have $500 in savings or $5 million. Do this now.

26 Stocks Moving in Wednesday's Pre-Market Session
14 Jul, 2021 FinancialContent

Gainers Yunhong CTI Ltd. (NASDAQ: CTIB) shares rose 35.6% to $3.54 in pre-market trading after jumping around 12% on ...

Best Biotech Penny Stocks to Buy in July 2021? 6 For Your Watchlist
12 Jul, 2021 FinancialContent
5 Hot Penny Stocks You Need to Know About in 2021
12 Jul, 2021 FinancialContent
INVESTIGATION ALERT: Halper Sadeh LLP Investigates RAVN, SHSP, ICBK, ACST; Shareholders are Encouraged to Contact the Firm
07 Jul, 2021 FinancialContent
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Acasti Pharma Inc. Merger
06 Jul, 2021 FinancialContent
INVESTIGATION ALERT: Halper Sadeh LLP Investigates ACST, CLDR, DISCA, GRA, TRMT, XEC; Shareholders are Encouraged to Contact the Firm
03 Jul, 2021 Yahoo! Finance

Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Acasti Pharma, Inc. - ACST
03 Jul, 2021 Yahoo! Finance

Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018-2020 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating Acasti Pharma, Inc. ("ACST" or the "Company") (ACST) relating to its proposed merger with Grace Therapeutics, Inc. ACST shareholders are expected to own approximately 55% of the combined company.

Best Biotech Penny Stocks In Summer 2021? 7 For Your Watchlist
01 Jul, 2021 FinancialContent
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
29 Jun, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Welcome back, trader! Let's get ready for another exciting day of investing with a look at the biggest pre-market stock movers for Tuesday. The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now It doesn’t matter if you have $500 in savings or $5 million. Do this now. Top Stock Picker Reveals His Next Potential 500% Winner

45 Biggest Movers From Yesterday
24 Jun, 2021 FinancialContent

Gainers Entera Bio Ltd. (NASDAQ: ENTX) shares surged 44.8% to close at $6.50 on Wednesday after the company reported topline ...

Acasti Pharma Inc.'s (CVE:ACST) Shift From Loss To Profit
24 Jun, 2021 Yahoo! Finance

We feel now is a pretty good time to analyse Acasti Pharma Inc.'s ( CVE:ACST ) business as it appears the company may...

Acasti Pharma Inc (ACST) is a NASDAQ Common Stock listed in , ,

970x250